🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchClinicalTrials.gov GLP-1 trial tracker — updated weekly Page 14

ClinicalTrials.gov GLP-1 trial tracker — updated weekly

TrialTracker_MD Mon, Feb 26, 2024 at 4:00 PM 411 replies 11,865 viewsPage 14 of 20
Admin
Administrator
2,456
9,812
Oct 2023
Online
Apr 1, 2025 at 7:58 PM#66

Moderator note: a post naming a supplier has been edited. Discuss suppliers in the review sections, not here. Carry on.

7 5PedsEndoPhilly, SleepDoc_PDX, RegAffairsDC and 4 others
Reply Quote Save Share Report
MASHdoc_SA
Member
456
2,345
Aug 2024
San Antonio, TX
Apr 10, 2025 at 12:07 AM#67
TrialTracker_MD said:
What actually changed my mind was the point about waiting for a trend instead of reading a single measurement, which is embarrassing in hindsight and…

This is my experience too, for whatever a second data point is worth.

8 6TrialTracker_MD, JennaRN, LabKate and 5 others
Reply Quote Save Share Report
mona_PHX
Member
189
890
Dec 2024
Phoenix, AZ
Apr 18, 2025 at 4:12 AM#68
TrialTracker_MD said:
What actually changed my mind was the point about waiting for a trend instead of reading a single measurement, which is embarrassing in hindsight and…

Coming at TrialTracker_MD’s question from a different direction. The distinction that resolves most of these threads is between what is true on average and what is true for one person. Both are real; they answer different questions and get quoted as if they were the same one.

Last edited: Apr 18, 2025 at 7:12 AM
9 7SallyK_inj, CryptoCarl, MariaRD and 6 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
raj_cambridge
Member
489
2,123
Jun 2024
Cambridge, MA
Apr 26, 2025 at 8:12 AM#69

One concrete data point for the thread. For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine. Half the figures circulating in this community trace back to a secondary summary that dropped a qualifier.

10 8PharmHunterJen, TomTeleRx, DoseLogDan and 7 others
Reply Quote Save Share Report
PharmHunterJen
Member
567
2,345
Jul 2024
Illinois
May 4, 2025 at 12:07 PM#70

One thing that is still open after TrialTracker_MD’s answer:

What did you change at the same time, and can you separate the two now?

32 5mike_mealprep, NicoleRaleigh, james_edin and 29 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register